Proposed Claim,Claim Type,Market,Validation Status,Regulatory Basis,Trigger Identified,Adjustment Rule Applied,Suggested Alternative
“Clinically proven to regrow hair”,Drug / therapeutic,US,Conditionally valid,Therapeutic hair growth claims fall under OTC drug regulation,"“regrow”, “clinically proven”",Remove biological regeneration + downgrade efficacy language to permitted drug wording,Rephrase to FDA OTC monograph-compliant language
“Treats hair loss”,Drug / therapeutic,US,Conditionally valid,Disease treatment claims require OTC drug classification,“treats”,Retain claim only under drug pathway with mandated wording,Use exact OTC Drug Facts wording
“Stimulates hair follicle regeneration”,Drug / biological,US,Not compliant,Biological regeneration claims exceed OTC monograph scope,"“stimulates”, “follicle regeneration”",Remove regeneration and follicle creation language entirely,Replace with “supports hair growth”
“Promotes hair growth”,Drug (OTC),US,Conditionally valid,Hair growth claims permitted only for approved OTC actives,“hair growth”,Restrict claim to approved active and drug context,Acceptable only with minoxidil + Drug Facts
“Non-hormonal hair growth solution”,Cosmetic / drug-adjacent,US,Conditionally valid,Claims must not contradict ingredient nature,“non-hormonal”,Replace absolute hormonal exclusion with narrower mechanism framing,Clarify as “non-androgenic”
“Reduces hair thinning”,Appearance-related,US,Conditionally valid,Cosmetic claims must avoid disease treatment implication,"“reduces” + condition framing",Reframe outcome as visual/appearance-based,“Improves the appearance of thinning hair”
“Supports the anagen phase”,Mechanism-based,US,Conditionally valid,Mechanistic biological claims imply pharmacological action,Hair cycle phase reference,Remove biological cycle terminology from consumer claims,Avoid consumer-facing use
“Improves scalp circulation”,Functional,US,Conditionally valid,Vascular claims scrutinized for therapeutic intent,“circulation”,Keep functional wording without medical causation,"Maintain vague, cosmetic framing"
“Hair growth cream”,Product descriptor,US,Conditionally valid,Product naming can imply drug classification,“hair growth”,Restrict product naming to OTC drug context,Acceptable only as OTC drug
“Clinically proven hair growth”,Drug,EU,Not compliant,Hair growth claims are medicinal in EU,"“hair growth”, “clinically proven”",Remove growth claim entirely or change regulatory category,Remove minoxidil or avoid EU
“Prevents hair loss”,Medicinal,EU,Not compliant,Disease prevention claims prohibited for cosmetics,“prevents”,Replace prevention language with appearance framing,“Improves the appearance of thinning hair”
“Strengthens hair roots”,Cosmetic,EU,Conditionally valid,Metaphorical claims allowed if non-physiological,“roots” (biological implication),"Keep metaphorical meaning, avoid follicle biology",Maintain abstract wording
“Improves the appearance of hair density”,Cosmetic,EU,Valid,Appearance-only cosmetic claims are permitted,None,No rewrite needed,Recommended
“Supports scalp health”,Cosmetic,EU,Valid,General cosmetic wellbeing claims allowed,None,No rewrite needed,Recommended
“Cooling and refreshing scalp feel”,Sensory,EU / US,Valid,Sensory claims permitted for cosmetics,None,No rewrite needed,Safe
“Helps maintain healthy-looking hair”,Cosmetic,EU / US,Valid,Standard cosmetic appearance claim,None,No rewrite needed,Preferred wording
“Activates Wnt/β-catenin signaling”,Scientific / mechanistic,EU / US,Not compliant,Molecular pathway claims imply pharmacological action,Explicit signaling pathway,Remove molecular mechanism references from consumer claims,Limit to internal or B2B materials
“Dermatologically tested”,Safety,EU / US,Valid,Safety claims must be truthful and verifiable,None (conditional on evidence),Require actual testing to support claim,Acceptable if substantiated
